179 related articles for article (PubMed ID: 15146948)
1. Mesenchymal stem cells and tissue engineering for orthopaedic surgery.
Gao J; Caplan AI
Chir Organi Mov; 2003; 88(3):305-16. PubMed ID: 15146948
[TBL] [Abstract][Full Text] [Related]
2. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
Caplan AI
J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
[TBL] [Abstract][Full Text] [Related]
3. Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury.
Fu X; Fang L; Li X; Cheng B; Sheng Z
Wound Repair Regen; 2006; 14(3):325-35. PubMed ID: 16808812
[TBL] [Abstract][Full Text] [Related]
4. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering through autologous mesenchymal stem cells.
Jorgensen C; Gordeladze J; Noel D
Curr Opin Biotechnol; 2004 Oct; 15(5):406-10. PubMed ID: 15464369
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells: clinical applications and biological characterization.
Barry FP; Murphy JM
Int J Biochem Cell Biol; 2004 Apr; 36(4):568-84. PubMed ID: 15010324
[TBL] [Abstract][Full Text] [Related]
7. Stem cells as vehicles for orthopedic gene therapy.
Gafni Y; Turgeman G; Liebergal M; Pelled G; Gazit Z; Gazit D
Gene Ther; 2004 Feb; 11(4):417-26. PubMed ID: 14724684
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
Arinzeh TL
Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit.
Koga H; Muneta T; Nagase T; Nimura A; Ju YJ; Mochizuki T; Sekiya I
Cell Tissue Res; 2008 Aug; 333(2):207-15. PubMed ID: 18560897
[TBL] [Abstract][Full Text] [Related]
10. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
11. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene.
Guo X; Zheng Q; Yang S; Shao Z; Yuan Q; Pan Z; Tang S; Liu K; Quan D
Biomed Mater; 2006 Dec; 1(4):206-15. PubMed ID: 18458408
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow mesenchymal stem cells: progress in bone/cartilage defect repair].
Lu X; Li S; Cheng J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):135-9. PubMed ID: 11951502
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells: stealth and suppression.
Devine SM; Peter S; Martin BJ; Barry F; McIntosh KR
Cancer J; 2001; 7 Suppl 2():S76-82. PubMed ID: 11777268
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells for tissue engineering and regenerative medicine.
Tae SK; Lee SH; Park JS; Im GI
Biomed Mater; 2006 Jun; 1(2):63-71. PubMed ID: 18460758
[TBL] [Abstract][Full Text] [Related]
15. [Repair of articular cartilage defects with "two-phase" tissue engineered cartilage constructed by autologous marrow mesenchymal stem cells and "two-phase" allogeneic bone matrix gelatin].
Yin Z; Zhang L; Wang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Aug; 19(8):652-7. PubMed ID: 16130396
[TBL] [Abstract][Full Text] [Related]
16. In vitro response of the bone marrow-derived mesenchymal stem cells seeded in a type-I collagen-glycosaminoglycan scaffold for skin wound repair under the mechanical loading condition.
Kobayashi M; Spector M
Mol Cell Biomech; 2009 Dec; 6(4):217-27. PubMed ID: 19899445
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
Beyer Nardi N; da Silva Meirelles L
Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
[TBL] [Abstract][Full Text] [Related]
18. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study of mesenchymal stem cells-seeded type I collagen-glycosaminoglycan matrices for cartilage repair.
Xiang Z; Hu W; Kong Q; Zhou H; Zhang X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Feb; 20(2):148-54. PubMed ID: 16529325
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
